Table 3.
Parameter | Adjusted Risk Ratio | 95% Confidence Interval |
---|---|---|
Ethnicity (African American)c | 0.54a | 0.41‐0.71 |
Age at study entry | 1.04a | 1.03‐1.06 |
Months treated PIs | 1.99a | 1.53‐2.60 |
Months treated NNRTIs | 2.48a | 1.91‐3.23 |
Preexisting hypertension | 2.30a | 1.68‐3.14 |
Preexisting dyslipidemia | 0.06a | 0.03‐0.12 |
Preexisting diabetes | 1.81b | 1.13‐2.91 |
Comorbid hepatitis C | 0.55b | 0.31‐0.97 |
Log viral load | 0.74a | 0.67‐0.83 |
Abbreviations: cART, combination antiretroviral therapy; HIV, human immunodeficiency virus; NNRTIs, nucleoside/nucleotide reverse transcriptase inhibitors; PIs, protease inhibitors.
Significant at P ≤0.001.
Significant at P ≤ 0.01.
Compared to White.